Our advanced medical weight-loss program featuring Ozempic and other GLP-1 receptor agonist medications is designed to provide you with individualized support, guidance, and clinical expertise every step of the way
Scientists have long recognised the potential benefits of transdermal drug delivery, including improved patient compliance, steady drug release, and avoidance of gastrointestinal degradation and first-pass metabolism
Once reconstituted from its lyophilised form, the peptide becomes vulnerable to hydrolysis, oxidation, aggregation, and microbial contamination making correct storage, handling, and adherence to sponsor-validated stability data essential for safety
Rapid weight loss, reduced caloric intake, and hormonal changes can accelerate that dip
WeGovy WeGovy, produced by Novo Nordisk, is the older of the second generation incretins containing Semaglutide
In a pre- and postnatal development study in pregnant cynomolgus monkeys, subcutaneous doses of 0.015, 0.075 and 0.15 mg/kg twice weekly (1.3-, 6.4- and 14-fold the MRHD) were administered from Gestation Day 16 to 140
